The origin and application of experimental autoimmune encephalomyelitis
- 1 November 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 7 (11), 904-912
- https://doi.org/10.1038/nri2190
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a model of the neuroimmune system responding to priming with central nervous system (CNS)-restricted antigens. It is an excellent model of post-vaccinal encephalitis and a useful model of many aspects of multiple sclerosis. EAE has been established in numerous species and is induced by priming with a large number of CNS-derived antigens. As a consequence, the pathogenesis, pathology and clinical signs vary significantly between experimental protocols. As I describe in this Timeline article, the reductionist approach taken in some lines of investigation of EAE resulted in a reliance on results obtained under a narrow range of conditions. Although such studies made important contributions to our molecular understanding of inflammation, T-cell activation, and MHC restriction, they did not advance as effectively our knowledge of the polyantigenic responses that usually occur in CNS immunopathology and autoimmunityKeywords
This publication has 85 references indexed in Scilit:
- Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatmentEuropean Journal of Neurology, 2006
- The coming of age for antigen‐specific therapy of multiple sclerosisEuropean Journal of Neurology, 2006
- Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytesEuropean Journal of Immunology, 2005
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabThe New England Journal of Medicine, 2005
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- The V-region disease hypothesis: evidence from autoimmune encephalomyelitisImmunology Today, 1989
- Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantroneClinical Immunology and Immunopathology, 1987
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisThe New England Journal of Medicine, 1987
- Myelin Basic Protein as an Encephalitogen in Encephalomyelitis and Polyneuritis Following Rabies VaccinationThe New England Journal of Medicine, 1987
- THE USE OF SPECIFIC "LYMPHOCYTE" ANTISERA TO INHIBIT HYPERSENSITIVE REACTIONS OF THE "DELAYED" TYPEThe Journal of Experimental Medicine, 1961